Quantitative approaches to drug development
We provide consultancy services to help our clients reduce uncertainty in research and regulatory questions, increasing confidence in the development of new medicines that can improve patients’ lives. Science and Services
About
Pharmetheus reduces uncertainty in all phases of drug development.
Featured content
This publication investigates a novel sustained-release octreotide subcutaneous injection that holds promise for individuals managing the rare chronic disorder acromegaly, caused by an excess of growth hormone. The research, developed in collaboration with Camurus, focuses on the pharmacokinetic (PK) properties of CAM2029, an innovative treatment designed to offer improved convenience and quality of life for patients.
The FDA recently announced its plans to reduce animal testing in preclinical studies in favour of more effective, human-relevant methods, using a range of New Approach Methodologies (NAMs). To help drug developers to navigate this new paradigm, our QSP Scientific Lead Lourdes Cucurull-Sanchez has co-authored a paper outlining how and when Quantitative Systems Pharmacology (QSP) among other in silico tools, can be used to phase out animal testing in a cost-efficient, timely and reliable way.
Pharmacometrics, a relatively young discipline using model-based methods for drug development, plays a vital role in internal decision-making and health authority interactions. However, the demand for skilled pharmacometricians currently exceeds the supply provided by academic institutions. Elodie Plan and Mats Karlsson took part in a group of experts, assembled by Peter Bonate, to provide insights in a publication in the…
How we work
Traceability, accountability, and independent quality control are of utmost importance to us, and embedded in our way of working.
Publications
Explore our scientific publications.
Explore our web
Model Informed Drug Development (MIDD) consulting services
A quantitative framework to support and inform development program strategies and decisions.
“Sharing with colleagues is why I love working here”
Sophie Peigné supports clients with expert and strategic advice in pharmacometrics as well as hands-on modeling analyses for compounds in all development phases.
History of Pharmetheus
Our journey is an exciting one. We began as a start-up that spinned off from Uppsala University. Today, we have grown into a global medium-sized company, adding value to drug development each day.